SCHEMBL18753740

SCHEMBL18753740

Cc1cc(C(=O)N2CCN(C(=O)c3c(F)cccc3F)CC2)ccc1N[SH](=O)=O

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 3/20 0.48
▸ HTT P42858 2/20 0.47
▸ ALDH1A1 P00352 9/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ KMT2A Q03164 3/20 0.43
▸ MEN1 O00255 2/20 0.43
▸ NPSR1 Q6W5P4 2/20 0.43
▸ MAPK1 P28482 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ CA12 O43570 1/20 0.43
▸ CA1 P00915 1/20 0.43
▸ CA2 P00918 1/20 0.43
▸ CA7 P43166 1/20 0.43
▸ CA9 Q16790 1/20 0.43
▸ CA14 Q9ULX7 1/20 0.43
▸ TSHR P16473 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18753448 0.89 LMNA (0.51) LMNAHTTALDH1A1CYP1A2CYP2C9
SCHEMBL18753353 0.88 HPGD (0.51) LMNAHTTALDH1A1SMN1; SMN2KMT2A
SCHEMBL18753487 0.87 ALDH1A1 (0.54) LMNAHTTALDH1A1KMT2AKDM4E
SCHEMBL18753318 0.87 KMT2A (0.59) LMNAHTTALDH1A1SMN1; SMN2KMT2A
SCHEMBL18753391 0.84 ALDH1A1 (0.48) LMNAHTTALDH1A1CYP1A2CYP2C9
SCHEMBL18753349 0.84 PKLR (0.41) LMNAHTTALDH1A1KMT2AMEN1
SCHEMBL18753484 0.82 MYC (0.54) LMNAALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL18753307 0.81 TSHR (0.47) LMNAHTTALDH1A1SMN1; SMN2KDM4E
SCHEMBL18753310 0.80 ALDH1A1 (0.41) LMNAHTTALDH1A1SMN1; SMN2KMT2A
SCHEMBL18753852 0.79 POLB (0.45) ALDH1A1KMT2AMEN1TSHRABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3241554-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2020-01-29 — — EP disclosed
EP-2448582-B1 QUINOLINE-8-SULFONAMIDE DERIVATIVES HAVING AN ANTICANCER ACTIVITY AGIOS PHARMACEUTICALS INC (US) 2017-04-19 — — EP disclosed
Send feedback